.
MergerLinks Header Logo

New Deal


Announced

Completed

PAG, CX Partners and Samara Capital completed the acquisition of Optimus Drugs.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

India

Majority

Pharmaceuticals

Single Bidder

Private

Cross Border

Private Equity

pharmaceutical company

Acquisition

Friendly

Completed

Synopsis

Edit

Investment companies PAG, CX Partners and Samara Capital completed the acquisition of Optimus Drugs, a Hyderabad, India-based pharmaceutical firm. Financial terms were not disclosed. "We are very pleased to be partnering with Dr. Reddy, Optimus Drugs and its employees to help them become one of the leading API players globally. Optimus is a clear leader in R&D, manufacturing, and intellectual property management. We’re looking forward to continuing their mission to deliver high quality, affordable health products across the globe," Nikhil Srivastava, PAG Partner and Managing Director, Head of India Private Equity.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US